{"schema_version":"1","generated_at":"2026-10-30T02:07:26.139Z","data_as_of":null,"url":"https://www.findmykol.com/kol/kelly-lindert","json_url":"https://www.findmykol.com/kol/kelly-lindert/profile.json","record_kind":"basic","profile_kind":"clinical","person":{"slug":"kelly-lindert","name":"Kelly Lindert","specialty":"Urology","specialty_raw":"Urology","therapeutic_area":"Genitourinary","therapeutic_areas":["Genitourinary"],"institution":"Pfizer","institution_url":"https://www.findmykol.com/institution/pfizer","city":"Arlington","state":"MA","region":{"label":"Northeast","url":"https://www.findmykol.com/region/northeast"}},"identifiers":{"npi":"1568099737","orcid":"0000-0003-4033-9853","openalex":"A5085573267"},"summary":"Kelly Lindert is a Genitourinary physician affiliated with Pfizer. OpenAlex indexes 35 publications with 1,438 citations (h-index 20).","overview":null,"focus":{"indications":[],"research_topics":["Genitourinary"]},"scholarship":{"works_count":35,"cited_by_count":1438,"h_index":20,"latest_activity_year":2026,"source":"works"},"publications":{"total":37,"shown":5,"withheld":32,"matched_by":"OpenAlex author record","recent":[{"title":"A Study to Investigate the Safety and Immunogenicity of Monovalent Omicron LP.8.1-Adapted BNT162b2 COVID-19 Vaccine in Adults ≥ 65 Years of Age and High-Risk Adults 18–64 Years of Age (Preliminary Results)","year":2026,"journal":"Vaccines","source_url":"https://doi.org/10.3390/vaccines14040350","status":"verified"},{"title":"Phase 3 Randomized Study Investigating the Safety, Tolerability, and Immunogenicity of a Combination Modified Messenger RNA Vaccine Against Influenza and COVID-19 in Healthy Adults","year":2026,"journal":"Vaccines","source_url":"https://doi.org/10.3390/vaccines14080677","status":"verified"},{"title":"Efficacy, Immunogenicity, and Safety of Modified mRNA Influenza Vaccine","year":2025,"journal":"New England Journal of Medicine","source_url":"https://doi.org/10.1056/nejmoa2416779","status":"verified"},{"title":"A Phase 1/2 Randomized Study to Evaluate the Safety, Tolerability, and Immunogenicity of Nucleoside-Modified Messenger RNA Influenza Vaccines in Healthy Adults","year":2025,"journal":"Vaccines","source_url":"https://doi.org/10.3390/vaccines13040383","status":"verified"},{"title":"Human Challenge Trial of a Nucleoside-Modified Messenger Ribonucleic Acid Influenza Vaccine","year":2025,"journal":"NEJM Evidence","source_url":"https://doi.org/10.1056/evidoa2500087","status":"verified"}],"source":"works"},"similar":[{"name":"Johanna Bendell","slug":"johanna-bendell","institution":"Pfizer","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/johanna-bendell","json_url":"https://www.findmykol.com/kol/johanna-bendell/profile.json"},{"name":"Yoshiko Umeyama","slug":"yoshiko-umeyama","institution":"Pfizer","url":"https://www.findmykol.com/kol/yoshiko-umeyama","json_url":"https://www.findmykol.com/kol/yoshiko-umeyama/profile.json"},{"name":"Lídia Sànchez-Riera","slug":"lidia-sanchez-riera","institution":"Pfizer","url":"https://www.findmykol.com/kol/lidia-sanchez-riera","json_url":"https://www.findmykol.com/kol/lidia-sanchez-riera/profile.json"},{"name":"Ariel Feldstein","slug":"ariel-feldstein","institution":"Pfizer","specialty":"Pediatric Gastroenterology","url":"https://www.findmykol.com/kol/ariel-feldstein","json_url":"https://www.findmykol.com/kol/ariel-feldstein/profile.json"},{"name":"Howard Scher","slug":"howard-scher","institution":"Memorial Sloan Kettering Cancer Center","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/howard-scher","json_url":"https://www.findmykol.com/kol/howard-scher/profile.json"},{"name":"Toni Choueiri","slug":"toni-choueiri","institution":"Dana-Farber Cancer Institute","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/toni-choueiri","json_url":"https://www.findmykol.com/kol/toni-choueiri/profile.json"},{"name":"Robert Motzer","slug":"robert-motzer","institution":"Memorial Sloan Kettering Cancer Center","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/robert-motzer","json_url":"https://www.findmykol.com/kol/robert-motzer/profile.json"},{"name":"Fred Saad","slug":"fred-saad","institution":"Centre hospitalier de l'Université de Montréal (CHUM)","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/fred-saad","json_url":"https://www.findmykol.com/kol/fred-saad/profile.json"}],"coverage":{"note":"A basic record from the physician directory. Sections absent here were not yet checked for this person, so absence means not yet looked, never none found.","not_yet_checked":["funding","congress","network","presence","recognition"]},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"publications":32}},"sources":{"orcid":{"name":"ORCID","url":"https://orcid.org","provides":"The verified researcher identity that anchors authorship"},"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts"}},"methodology_url":"https://www.findmykol.com/about#methodology"}